Research needs for neutron capture therapy
Conference
·
OSTI ID:155260
Key issues and questions addressed by the workshop related to optimization of Boron Neutron Capture Therapy (BNCT), in general, and to the possibility of success of the present BNCT trials at Brookhaven National Laboratory (BNL) and Massachusetts Institute of Technology (MIT), in particular. Both trials use nuclear fission reactors as neutron sources for BNCT of glioblastoma multiforme (BNL) and of deep seated melanoma (MIT). Presentations and discussions focussed on optimal boron-labeled compounds, mainly for brain tumors such as glioblastoma multiforme, and the best mode of compound delivery to the tumor. Also, optimizing neutron irradiation with dose delivery to the tumor cells and the issues of dosimetry of BNCT especially in the brain were discussed. Planning of treatment and of follow-up of patients, coordination of BNCT at various treatment sites, and the potential of delivering BNCT to various types of cancer with an appropriately tailored protocol were additional issues. The need for multicentric interdisciplinary cooperation among the different medical specialties was highlighted.
- Research Organization:
- USDOE Office of Energy Research, Washington, DC (United States). Office of Health and Environmental Research
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- OSTI ID:
- 155260
- Report Number(s):
- DOE/ER--0665; CONF-9505308--EXEC.SUMM.; ON: DE96003085; NC: NONE
- Country of Publication:
- United States
- Language:
- English
Similar Records
A Phase 1 trial of intravenous boronophenylalanine-fructose complex in patients with glioblastoma multiforme
Initiation of a phase-I trial of neutron capture therapy at the MIT research reactor
License amendment for neutron capture therapy at the MIT research reactor
Conference
·
Tue Oct 01 00:00:00 EDT 1996
·
OSTI ID:390617
Initiation of a phase-I trial of neutron capture therapy at the MIT research reactor
Journal Article
·
Sat Dec 30 23:00:00 EST 1995
· Transactions of the American Nuclear Society
·
OSTI ID:411518
License amendment for neutron capture therapy at the MIT research reactor
Conference
·
Thu Dec 31 23:00:00 EST 1992
· Transactions of the American Nuclear Society; (United States)
·
OSTI ID:6911808